October 15, 2015JAMA Oncology205 citationsOpen Access
Patient Income Level and Cancer Clinical Trial Participation
Key Points
Key points are not available for this paper at this time.
Abstract
ing to follow-up biopsies. Outcomes measured include changes in clinical management and incidence of false-positive findings defined as biopsy-evaluated PET/CT findings nondiagnostic for melanoma. Fisher exact tests were used to compare clinical factors with PET/CT use.